TREOVIR
TREOVIR
Social Links:
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Bala Cynwyd, Pennsylvania, United States
Country:
United States
Website Url:
http://www.treovir.com
Total Employee:
1+
Status:
Active
Contact:
(703) 786-3790
Technology used in webpage:
Euro Google Maps U.S. Server Location Google Maps API
Similar Organizations
Essential Biotechnology
Essential Biotechnology is a clinical research company.
Nexuspiral
Nexuspiral is a biotechnology research company.
NWABR
NWABR is a biomedical research company.
SoyMeds
SoyMeds is a biotechnology research company
Unilabs
Unilabs is a biotechnology research company.
Official Site Inspections
http://www.treovir.com
- Host name: 178.0.153.160.host.secureserver.net
- IP address: 160.153.0.178
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Treovir"
Home - Treovir Inc.
Treovirโs G207 Therapy demonstrated improved survival in a Phase 1 study without any serious side effects. Treovir strives to change the course of brain tumor therapies, improve survival โฆSee details»
About - Treovir Inc.
WHO WE ARE Treovir, Inc. Treovir was founded in 2019 to develop and commercialize G207 for recurrent glioblastoma in children. G207 is a targeted oncolytic immunotherapy that has โฆSee details»
Treovir - Crunchbase Company Profile & Funding
Organization. Treovir . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Treovir is located in Bala Cynwyd, Pennsylvania, United States. โฆSee details»
Management - Treovir Inc.
Treovirโs Management, Founders and Advisors have decades of experience developing G207 and oncolytic HSV therapies for the treatment of brain tumors and other cancers. Their esteemed scientific careers have produced hundreds โฆSee details»
TREOVIR, LLC - VentureRadar
Treovir was founded in 2019 to develop and commercialize G207 for recurrent glioblastoma in children. G207 is a targeted oncolytic immunotherapy that has demonstrated improved โฆSee details»
Treovir Inc. - LinkedIn
Treovir Inc. | 102 followers on LinkedIn. For the kids | Treovir was established in 2019 to develop and commercialize G207, an oncolytic HSV virus for the treatment of pediatric brain tumors. A ...See details»
Treovir 2025 Company Profile: Valuation, Funding & Investors
Treovir General Information Description. Developer of a targeted oncolytic immunotherapy designed to prevent cancer-related death in pediatric patients. The company offers โฆSee details»
Treovir, Inc. Company Profile | Birmingham, AL | Competitors ...
Find company research, competitor information, contact details & financial data for Treovir, Inc. of Birmingham, AL. Get the latest business insights from Dun & Bradstreet.See details»
Treovir Company Profile - Office Locations, Competitors ... - Craft
Treovir is a biological research company that provides therapeutic solutions for cancer treatment. It develops and commercializes G207, oncolytic immunotherapy for the treatment of pediatric โฆSee details»
Treovir Headquarters and Office Locations - Craft.co
Treovir. Overview; Locations; Financials; Operating Metrics; Human Capital; Key People; Competitors; Supplier Risk; Treovir Headquarters and Office Locations. Header placeholder โฆSee details»
Treovir Inc - Drug pipelines, Patents, Clinical trials - Synapse
Jan 23, 2025 Explore Treovir Inc with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news, Disease Domain:Nervous System Diseases, Neoplasms, Technology โฆSee details»
Treovir - Company Profile - Tracxn
Jan 10, 2025 Treovir is a developer of therapeutic solutions for cancer treatment. It has developed G207 that is oncolytic immunotherapy that helps in treating pediatric brain tumors. โฆSee details»
Treovir - Overview, News & Similar companies | ZoomInfo.com
Treovir. Business Services · Pennsylvania, United States · <25 Employees. Treovir was established in 2019 to develop and commercialize G207, an oncolytic HSV virus for the โฆSee details»
Treovir and Matica Bio Forms Strategic Partnership to Advance ...
Dec 4, 2024 Treovir is a clinical-stage biopharmaceutical company focused on development and commercialization of oncolytic Herpes Simplex Viruses (oHSV) for treatment of malignant โฆSee details»
Treovir Inc (Treovir Inc) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ_ๆๆฐ โฆ
About Treovir, Inc. Treovir is a clinical-stage biopharmaceutical company focused on development and commercialization of oncolytic Herpes Simplex Viruses (oHSV) for treatment of malignant โฆSee details»
Treovir and Matica Bio
Dec 5, 2024 Treovir is a clinical-stage biopharmaceutical company focused on development and commercialization of oncolytic Herpes Simplex Viruses (oHSV) for treatment of malignant โฆSee details»
Treovir - Products, Competitors, Financials, Employees, โฆ
Treovir is a biopharmaceutical company focused on developing innovative treatments for pediatric brain tumors. The company's main product is G207, an oncolytic HSV virus therapy designed โฆSee details»
CDMO Matica Bio Partners with Treovir for Pediatric Cancer Therapy
Dec 4, 2024 Matica Biotechnology, a contract development and manufacturing organization (CDMO) specializing in viral vector development and manufacturing, has partnered with โฆSee details»
Treovir and Matica Bio Forms Strategic Partnership to Advance ...
Dec 4, 2024 COLLEGE STATION, Texas--(BUSINESS WIRE)--#genetherapy--Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization โฆSee details»
Treovir and Matica Bio Forms Strategic Partnership to Advance ...
News. Treovir and Matica Bio Forms Strategic Partnership to Advance Innovative Therapies for Pediatric Brain Tumors December 4, 2024See details»